News

The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...
The Food and Drug Administration (FDA) has approved Enflonsia ™ (clesrovimab-cfor) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants who ...
Fluoride supplements have been used in the United States for decades and have proven to be safe and effective for decreasing cavities.
“GSK essentially just renamed Flovent,” the attorney general said in its complaint ... "GSK put corporate greed ahead of the health and safety of Arizona's families and children," Attorney General ...
FRIDAY, May 2, 2025 (HealthDay News) -- For children using fluticasone propionate, the withdrawal of the brand-name drug (Flovent) was associated with increased discontinuation of inhaled steroid ...
More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says. In 2024, GlaxoSmithKline withdrew Flovent from the market.
In 2024, GlaxoSmithKline withdrew Flovent from the market. The inhaler was commonly prescribed to prevent asthma attacks in children. The pharma company continued to sell a chemically identical ...
A new study suggests the discontinuation of common asthma drug Flovent was linked to a higher rate of children halting inhaled steroid therapy altogether. In January 2024, a manufacturer stopped ...
The market withdrawal of the brand-name asthma drug fluticasone propionate (Flovent) was linked to increased discontinuation of inhaled steroid therapy among children who had used the drug ...
1 Few ICS options are approved for use in infants and young children (defined as 4 years and under). A previously commonly prescribed ICS option in this age range included fluticasone propionate, sold ...
And it also deterred private insurers from covering the generic, which reduced access and exacerbated a shortage of the primary alternative for children. Not only has the gambit “fleeced ...